Clinical Trial Update: Use of Vasopressin Following the Fontan Operation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial assessed vasopressin after the Fontan operation to treat pleural effusions in patients with single-ventricular congenital heart disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Effusion
• Single-ventricular Congenital Heart Disease

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pleural Effusion, Single-ventricle | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-10-09